Results 51 to 60 of about 416,692 (196)

Prolonging herd immunity to cholera via vaccination: Accounting for human mobility and waning vaccine effects.

PLoS Neglected Tropical Diseases, 2018
BackgroundOral cholera vaccination is an approach to preventing outbreaks in at-risk settings and controlling cholera in endemic settings. However, vaccine-derived herd immunity may be short-lived due to interactions between human mobility and imperfect ...
Corey M Peak, Amanda L Reilly, Andrew S Azman, Caroline O Buckee   +3 more
doaj   +1 more source

Private demand for cholera vaccines in Beira, Mozambique.

, 2007
In the summer of 2005, we interviewed 996 randomly selected respondents in Beira, Mozambique concerning their willingness and ability to pay for cholera vaccine for themselves and for other household members.
Whittington, Dale, Cumbane, Arnaldo, Lazaro, Nivalda, Songane, Francisco F, Deen, Jacqueline, von Seidlein, Lorenz, Jeuland, Marc, Nyamete, Andrew, Lucas, Marcelino ES, MacMahon, Melissa, Barreto, Avertino   +10 more
core   +1 more source

Effectiveness of reactive oral cholera vaccination in rural Haiti: a case-control study and bias-indicator analysis

The Lancet Global Health, 2015
Background: Between April and June, 2012, a reactive cholera vaccination campaign was done in Haiti with an oral inactivated bivalent whole-cell vaccine.
Dr. Louise C Ivers, MBBCh, Isabelle J Hilaire, MD, Jessica E Teng, MPH, Charles P Almazor, MD, J Gregory Jerome, MD, Ralph Ternier, MD, Jacques Boncy, MD, Josiane Buteau, MD, Prof. Megan B Murray, MD, Jason B Harris, MD, Molly F Franke, ScD   +10 more
doaj   +1 more source

Feasibility and costs of a targeted cholera vaccination campaign in Ethiopia

Human Vaccines & Immunotherapeutics, 2018
Shanchol™, a WHO-prequalified oral cholera vaccine (OCV), has been used to control endemic cholera in Asia, as well as in emergencies and outbreaks elsewhere.
Samuel Teshome, Sachin Desai, Jerome H. Kim, Dires Belay, Vittal Mogasale   +4 more
doaj   +1 more source

Introduction to the cholera vaccine session [PDF]

01-Cholera-Sanchez-508 ...

core   +2 more sources

Oral cholera vaccine use in Zanzibar: socioeconomic and behavioural features affecting demand and acceptance

BMC Public Health, 2009
Background Cholera remains a serious public health problem in low-income countries despite efforts in the past to promote oral rehydration therapy as major treatment.
Chaignat Claire-Lise, Weiss Mitchell G, Pach Al, Ali Said M, Hutubessy Raymond, Schaetti Christian, Khatib Ahmed M   +6 more
doaj   +1 more source

Process for oral cholera vaccine deployment.

, 2014
Process for oral cholera vaccine deployment.
Dang Duc Anh (232106), Jacqueline L. Deen (148731), Anna Lena Lopez (92298), Vu Dinh Thiem (232108), Hung Thi Mai Tran (624674), Nguyen Van Cuong (624675), Lorenz von Seidlein (45473), David A. Sack (219219), Mohammad Ali (73095)   +8 more
core   +1 more source

Oral cholera vaccine in cholera prevention and control, Malawi [PDF]

, 2018
With limited global supplies of oral cholera vaccine, countries need to identify priority areas for vaccination while longer-term solutions, such as water and sanitation infrastructure, are being ...
Masuku, H, Philippe Cavailler, Emily MacDonald, Storn Kabuluzi, Msyamboza, K, Kelias Msyamboza, Pezzoli, L, Justin Lessler, Shaffer, A, MacDonald, E, Sean M Moore, Bruce Reeder, Reeder, B, Allison Shaffer, Andrew S Azman, Cavailler, P, Azman, AS, Moore, SM, Maurice M’bangombe, Humphreys Masuku, Moore, S.M, Kabuluzi, S, Lessler, J, Francesco Grandesso, M'bangombe, M, Palomares, A, Lorenzo Pezzoli, Ngwira, B, Namseon Beck, Adriana Palomares, M’Bangombe, M, Beck, N, Senbete, M, Grandesso, F, Mesfin Senbete, Bagrey Ngwira, Azman, A.S   +36 more
core   +1 more source

A randomized, placebo-controlled trial of the bivalent killed, whole-cell, oral cholera vaccine in adults and children in a cholera endemic area in Kolkata, India. [PDF]

PLoS ONE, 2008
An effective vaccine against cholera has been used for public health purposes in Vietnam since the 1990s. This vaccine was reformulated to meet WHO requirements.
Dilip Mahalanabis, Anna Lena Lopez, Dipika Sur, Jacqueline Deen, Byomkesh Manna, Suman Kanungo, Lorenz von Seidlein, Rodney Carbis, Seung Hyun Han, Seong Hye Shin, Stephen Attridge, Raman Rao, Jan Holmgren, John Clemens, Sujit K Bhattacharya   +14 more
doaj   +1 more source

Evaluation of a Novel Inaba Cholera Conjugate Vaccine in Mice [PDF]

, 2015
Vibrio cholerae is a non-invasive Gram-negative enteric pathogen that causes cholera, a severe dehydrating diarrheal illness of humans. Cholera is responsible for substantial morbidity and mortality in both endemic and epidemic settings.
Eckhoff, Grace
core   +4 more sources